Pfizer Inc. (PFE) 13D/13G Filings for Spero Therapeutics, Inc. (SPRO)

Pfizer Inc. 13D and 13G filings for Spero Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-07-09
4:25 pm
Purchase
2021-06-3013GSpero Therapeutics, Inc.
SPRO
PFIZER INC
PFE
2,362,348
7.370%
2,362,348increase
(New Position)
Filing